158 related articles for article (PubMed ID: 32104432)
1. Influence of solvent mixtures on HPMCAS-celecoxib microparticles prepared by electrospraying.
Bohr A; Wang Y; Beck-Broichsitter M; Yang M
Asian J Pharm Sci; 2018 Nov; 13(6):584-591. PubMed ID: 32104432
[TBL] [Abstract][Full Text] [Related]
2. Preparation and evaluation of posaconazole-loaded enteric microparticles in rats.
Yang M; Dong Z; Zhang Y; Zhang F; Wang Y; Zhao Z
Drug Dev Ind Pharm; 2017 Apr; 43(4):618-627. PubMed ID: 28005452
[TBL] [Abstract][Full Text] [Related]
3. Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu.
Curatolo W; Nightingale JA; Herbig SM
Pharm Res; 2009 Jun; 26(6):1419-31. PubMed ID: 19277850
[TBL] [Abstract][Full Text] [Related]
4. Supersaturated controlled release matrix using amorphous dispersions of glipizide.
Lu Z; Yang Y; Covington RA; Bi YV; Dürig T; Ilies MA; Fassihi R
Int J Pharm; 2016 Sep; 511(2):957-68. PubMed ID: 27492020
[TBL] [Abstract][Full Text] [Related]
5. Effect of supersaturation on the oral bioavailability of paclitaxel/polymer amorphous solid dispersion.
Miao L; Liang Y; Pan W; Gou J; Yin T; Zhang Y; He H; Tang X
Drug Deliv Transl Res; 2019 Feb; 9(1):344-356. PubMed ID: 30187352
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical microparticle engineering with electrospraying: the role of mixed solvent systems in particle formation and characteristics.
Bohr A; Wan F; Kristensen J; Dyas M; Stride E; Baldursdottír S; Edirisinghe M; Yang M
J Mater Sci Mater Med; 2015 Feb; 26(2):61. PubMed ID: 25631263
[TBL] [Abstract][Full Text] [Related]
7. Impact of HPMCAS on the Dissolution Performance of Polyvinyl Alcohol Celecoxib Amorphous Solid Dispersions.
Monschke M; Wagner KG
Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32545270
[TBL] [Abstract][Full Text] [Related]
8. Effects of Surfactants on Itraconazole-HPMCAS Solid Dispersion Prepared by Hot-Melt Extrusion I: Miscibility and Drug Release.
Solanki NG; Lam K; Tahsin M; Gumaste SG; Shah AV; Serajuddin ATM
J Pharm Sci; 2019 Apr; 108(4):1453-1465. PubMed ID: 30395834
[TBL] [Abstract][Full Text] [Related]
9. Impact of Hydroxypropyl Methylcellulose Acetate Succinate Critical Aggregation Concentration on Celecoxib Supersaturation.
Bristol AN; Lamm MS; Li Y
Mol Pharm; 2021 Dec; 18(12):4299-4309. PubMed ID: 34738825
[TBL] [Abstract][Full Text] [Related]
10. Enhanced oral delivery of celecoxib via the development of a supersaturable amorphous formulation utilising mesoporous silica and co-loaded HPMCAS.
Lainé AL; Price D; Davis J; Roberts D; Hudson R; Back K; Bungay P; Flanagan N
Int J Pharm; 2016 Oct; 512(1):118-125. PubMed ID: 27543354
[TBL] [Abstract][Full Text] [Related]
11. Carrier-Free Inhalable Dry Microparticles of Celecoxib: Use of the Electrospraying Technique.
Jahangiri A; Nokhodchi A; Asare-Addo K; Salehzadeh E; Emami S; Yaqoubi S; Hamishehkar H
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371841
[TBL] [Abstract][Full Text] [Related]
12. Deconstructing HPMCAS: Excipient Design to Tailor Polymer-Drug Interactions for Oral Drug Delivery.
Ting JM; Navale TS; Jones SD; Bates FS; Reineke TM
ACS Biomater Sci Eng; 2015 Oct; 1(10):978-990. PubMed ID: 33429529
[TBL] [Abstract][Full Text] [Related]
13. Utility of Films to Anticipate Effect of Drug Load and Polymer on Dissolution Performance from Tablets of Amorphous Itraconazole Spray-Dried Dispersions.
Honick M; Sarpal K; Alayoubi A; Zidan A; Hoag SW; Hollenbeck RG; Munson EJ; Polli JE
AAPS PharmSciTech; 2019 Nov; 20(8):331. PubMed ID: 31677012
[TBL] [Abstract][Full Text] [Related]
14. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA
AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
[TBL] [Abstract][Full Text] [Related]
15. Improved human bioavailability of vemurafenib, a practically insoluble drug, using an amorphous polymer-stabilized solid dispersion prepared by a solvent-controlled coprecipitation process.
Shah N; Iyer RM; Mair HJ; Choi DS; Tian H; Diodone R; Fähnrich K; Pabst-Ravot A; Tang K; Scheubel E; Grippo JF; Moreira SA; Go Z; Mouskountakis J; Louie T; Ibrahim PN; Sandhu H; Rubia L; Chokshi H; Singhal D; Malick W
J Pharm Sci; 2013 Mar; 102(3):967-81. PubMed ID: 23280631
[TBL] [Abstract][Full Text] [Related]
16. Amorphous solid dispersions of darunavir: Comparison between spray drying and electrospraying.
Smeets A; Koekoekx R; Clasen C; Van den Mooter G
Eur J Pharm Biopharm; 2018 Sep; 130():96-107. PubMed ID: 29928980
[TBL] [Abstract][Full Text] [Related]
17. Stability and solubility enhancement of ellagic acid in cellulose ester solid dispersions.
Li B; Harich K; Wegiel L; Taylor LS; Edgar KJ
Carbohydr Polym; 2013 Feb; 92(2):1443-50. PubMed ID: 23399175
[TBL] [Abstract][Full Text] [Related]
18. Investigating molecular interactions of high-loaded glipizide-HPMCAS microparticles by integrated experimental and modeling techniques.
Li Q; Zhao Q; Jing Q; Ma X; Chen N; Ren G; Ouyang D; Ren F
Eur J Pharm Sci; 2019 Apr; 131():127-135. PubMed ID: 30735823
[TBL] [Abstract][Full Text] [Related]
19. Physical properties and solubility studies of Nifedipine-PEG 1450/HPMCAS-HF solid dispersions.
Haware RV; Vinjamuri BP; Gavireddi M; Dave VS; Gupta D; Chougule MB; Stagner WC
Pharm Dev Technol; 2019 Jun; 24(5):550-559. PubMed ID: 30175691
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions.
Tanno F; Nishiyama Y; Kokubo H; Obara S
Drug Dev Ind Pharm; 2004 Jan; 30(1):9-17. PubMed ID: 15000425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
